Your browser doesn't support javascript.
Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies.
Petzer, Verena; Steiner, Normann; Angelova-Unterberger, Olga; Hetzenauer, Gabriele; Philipp-Abbrederis, Kathrin; Willenbacher, Ella; Feistritzer, Clemens; Willenbacher, Wolfgang; Rudzki, Jakob; Stauder, Reinhard; Kocher, Florian; Seeber, Andreas; Pircher, Andreas; Tymoszuk, Piotr; Isara, Christian; Egger, Alexander; Fux, Vilmos; Anliker, Markus; Gunsilius, Eberhard; Nachbaur, David; Schmidt, Stefan; Wolf, Dominik.
  • Petzer V; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria.
  • Steiner N; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria.
  • Angelova-Unterberger O; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria.
  • Hetzenauer G; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria.
  • Philipp-Abbrederis K; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria.
  • Willenbacher E; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria.
  • Feistritzer C; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria.
  • Willenbacher W; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria.
  • Rudzki J; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria.
  • Stauder R; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria.
  • Kocher F; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria.
  • Seeber A; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria.
  • Pircher A; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria.
  • Tymoszuk P; Data Analytics As a Service Tirol, DAAS Tirol, Innsbruck, Austria.
  • Isara C; Central Institute of Clinical Chemistry and Laboratory Medicine Medical University of Innsbruck, Austria.
  • Egger A; Central Institute of Clinical Chemistry and Laboratory Medicine Medical University of Innsbruck, Austria.
  • Fux V; Central Institute of Clinical Chemistry and Laboratory Medicine Medical University of Innsbruck, Austria.
  • Anliker M; Central Institute of Clinical Chemistry and Laboratory Medicine Medical University of Innsbruck, Austria.
  • Gunsilius E; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria.
  • Nachbaur D; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria.
  • Schmidt S; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria.
  • Wolf D; Department of Internal Medicine V (Hematology and Oncology), Comprehensive Cancer Center Innsbruck (CCCI), Medical University Innsbruck (MUI), Innsbruck, Austria.
Hemasphere ; 6(3): e686, 2022 Mar.
Article in English | MEDLINE | ID: covidwho-1795007

Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines Language: English Journal: Hemasphere Year: 2022 Document Type: Article Affiliation country: Hs9.0000000000000686

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines Language: English Journal: Hemasphere Year: 2022 Document Type: Article Affiliation country: Hs9.0000000000000686